StonvexLoading…
StonvexStonvexStonvexCore line items from MELI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.34B | $15.14B | $10.49B | $7.45B |
Operating Income | $3.20B | $2.63B | $2.21B | $1.07B |
Net Income | $2.00B | $1.91B | $987.00M | $482.00M |
EPS (Diluted) | $39.40 | $37.69 | $19.46 | $9.53 |
Total Assets | $42.67B | $25.20B | $17.61B | $13.74B |
Total Liabilities | $35.92B | $20.84B | $14.54B | $11.91B |
Cash & Equivalents | $3.67B | $2.63B | $2.56B | $1.91B |
Free Cash Flow OCF − CapEx | $10.77B | $7.06B | $4.63B | $2.49B |
Shares Outstanding | 50.70M | 50.70M | 50.70M | 50.26M |